144 related articles for article (PubMed ID: 7041568)
21. Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2).
Camussi G; Tetta C; Segoloni G; Chiara Deregibus M; Bussolino F
Agents Actions; 1981 Dec; 11(6-7):550-3. PubMed ID: 7041569
[TBL] [Abstract][Full Text] [Related]
22. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
Coëffier E; Joseph D; Vargaftig BB
J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
[TBL] [Abstract][Full Text] [Related]
23. Release of PAF-acether from human blood monocytes.
Arnoux B; Jouvin-Marche E; Arnoux A; Benveniste J
Agents Actions; 1982 Dec; 12(5-6):713-6. PubMed ID: 7164946
[TBL] [Abstract][Full Text] [Related]
24. Saturated and unsaturated 1-O-alkyl-2-O-acetoyl-sn-glycero-3-phosphocholines derived from ratfish liver oil: effect on human leukocyte migration.
Czarnetzki BM; Muramatsu T
Chem Phys Lipids; 1981 Dec; 29(4):309-15. PubMed ID: 7318048
[TBL] [Abstract][Full Text] [Related]
25. Biosynthesis of platelet-activating factor (PAF)acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages.
Mencia-Huerta JM; Roubin R; Morgat JL; Benveniste J
J Immunol; 1982 Aug; 129(2):804-8. PubMed ID: 7086143
[TBL] [Abstract][Full Text] [Related]
26. Effect of bacterial products on neutrophil chemotaxis.
Kalmar JR; Van Dyke TE
Methods Enzymol; 1994; 236():58-87. PubMed ID: 7968641
[No Abstract] [Full Text] [Related]
27. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.
Benveniste J; Roubin R; Chignard M; Jouvin-Marche E; Le Couedic JP
Agents Actions; 1982 Dec; 12(5-6):711-3. PubMed ID: 7164945
[TBL] [Abstract][Full Text] [Related]
28. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.
Coëffier E; Borrel MC; Lefort J; Chignard M; Broquet C; Heymans F; Godfroid JJ; Vargaftig BB
Eur J Pharmacol; 1986 Nov; 131(2-3):179-88. PubMed ID: 3816952
[TBL] [Abstract][Full Text] [Related]
29. Effects of various barriers on platelet-activating factor-induced neutrophil chemotaxis.
Casale TB; Abbas MK
J Allergy Clin Immunol; 1991 Feb; 87(2):565-74. PubMed ID: 1993814
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT
Br J Pharmacol; 1989 Aug; 97(4):1251-7. PubMed ID: 2551444
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function.
Coffer PJ; Geijsen N; M'rabet L; Schweizer RC; Maikoe T; Raaijmakers JA; Lammers JW; Koenderman L
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):121-30. PubMed ID: 9405284
[TBL] [Abstract][Full Text] [Related]
32. Biosynthesis of paf-acether. X. Phorbol myristate acetate-induced paf-acether biosynthesis and acetyltransferase activation in human neutrophils.
Leyravaud S; Bossant MJ; Joly F; Bessou G; Benveniste J; Ninio E
J Immunol; 1989 Jul; 143(1):245-9. PubMed ID: 2732470
[TBL] [Abstract][Full Text] [Related]
33. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs.
Fitzgerald MF; Moncada S; Parente L
Br J Pharmacol; 1986 May; 88(1):149-53. PubMed ID: 3708213
[TBL] [Abstract][Full Text] [Related]
34. Degree of neutrophil chemotaxis is dependent upon the chemoattractant and barrier.
Casale TB; Abbas MK; Carolan EJ
Am J Respir Cell Mol Biol; 1992 Jul; 7(1):112-7. PubMed ID: 1320901
[TBL] [Abstract][Full Text] [Related]
35. Dissociation of the neutrophill functions of exocytosis and chemotaxis.
Spilberg I; Mandell B; Mehta J; Sullivan T; Simchowitz L
J Lab Clin Med; 1978 Aug; 92(2):297-302. PubMed ID: 681815
[TBL] [Abstract][Full Text] [Related]
36. Actions of platelet activating factor (PAF) homologues and their combinations on neutrophil chemokinesis and cutaneous inflammatory responses in man.
Archer CB; Cunningham FM; Greaves MW
J Invest Dermatol; 1988 Jul; 91(1):82-5. PubMed ID: 3385217
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis.
Thomsen MK; Larsen CG; Thomsen HK; Kirstein D; Skak-Nielsen T; Ahnfelt-Rønne I; Thestrup-Pedersen K
J Invest Dermatol; 1991 Feb; 96(2):260-6. PubMed ID: 1846901
[TBL] [Abstract][Full Text] [Related]
38. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor.
Pinckard RN; Showell HJ; Castillo R; Lear C; Breslow R; McManus LM; Woodard DS; Ludwig JC
J Immunol; 1992 Jun; 148(11):3528-35. PubMed ID: 1316919
[TBL] [Abstract][Full Text] [Related]
39. Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.
Chignard M; Wal F; Lefort J; Vargaftig BB
Eur J Pharmacol; 1982 Feb; 78(1):71-9. PubMed ID: 6804248
[TBL] [Abstract][Full Text] [Related]
40. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil.
Triggiani M; Goldman DW; Chilton FH
Biochim Biophys Acta; 1991 Jun; 1084(1):41-7. PubMed ID: 1647203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
